[Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002648:Child; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use*; D008875:Middle Aged; D011437:Propylamines / Q000627:therapeutic use*; D013610:Tachycardia / Q000503:physiopathology; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D011437:Propylamines; D008801:Mexiletine
Efficacia antiaritmica della mexiletina nelle aritmie sopraventricolari, nel W.P.W. e nelle aritmie ipercinetiche ventricolari iterative persistenti. Considerazioni su questi meno noti effetti terapeutici.